{"id":"W2911882091","doi":"10.1007/s00262-019-02307-x","title":"Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"Canadian Institutes of Health Research; Princess Margaret Cancer Foundation","keywords":"Medicine; Melanoma; Clinical endpoint; Response Evaluation Criteria in Solid Tumors; Aldesleukin; Population; Adverse effect; Chemotherapy; Interleukin 2; Immune system; Internal medicine; Oncology; Immunotherapy; Gastroenterology; Phases of clinical research; Clinical trial; Immunology; Cancer research","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005626783,0.0004607633,0.001385797,0.0002378605,0.0001470063,0.00002708391,0.0003014122,0.0001767263,0.0009428244],"category_scores_gemma":[0.00003799174,0.0003157114,0.0002257435,0.0002883936,0.0008663993,0.0001549944,0.00005344302,0.0004624094,0.000005032154],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002243499,"about_ca_system_score_gemma":0.000983078,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001274509,"about_ca_topic_score_gemma":0.0000106626,"domain_scores_codex":[0.9971805,0.0002877729,0.0008990982,0.0006806095,0.0003380927,0.000613948],"domain_scores_gemma":[0.9972658,0.0007011684,0.0006508058,0.0007693291,0.0005191393,0.00009375253],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6345927,0.004996504,0.0180884,0.000103825,0.0028236,0.00001508264,0.00158386,0.000003922362,0.1081587,0.00002124045,0.00003359243,0.2295786],"study_design_scores_gemma":[0.7199928,0.1953063,0.01338759,0.0002955563,0.0001721327,0.00005084219,0.0005967217,0.0001305101,0.06595097,0.00002871257,0.00360851,0.0004792869],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9867945,0.006682223,0.00007584942,0.0001339698,0.000426055,0.005554803,0.00006691745,0.00005821915,0.0002074716],"genre_scores_gemma":[0.9931939,0.002960771,0.001560392,0.0004514671,0.00008244266,0.0006766532,0.0000774631,0.0001306614,0.0008662666],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2290993,"threshold_uncertainty_score":0.9999704,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03161818977587048,"score_gpt":0.3569993678410537,"score_spread":0.3253811780651832,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}